MLchartDataset catalogue

Hydroxydaunorubicin

Term · Oncology and biomedicine · MLC-T-ONC-004048

A drug that comes from the bacterium Streptomyces peucetius and is used alone or with other drugs to treat many types of cancer, including leukemia, lymphoma, neuroblastoma, sarcoma, Wilms tumor, and certain cancers of the lung, breast, stomach, ovary, thyroid, and bladder. It is also being studied in the treatment of other types of cancer. Hydroxydaunorubicin damages the cell’s DNA and may kill cancer cells. It also blocks a certain enzyme needed for cell division and DNA repair. Hydroxydaunorubicin is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called Adriamycin and doxorubicin hydrochloride.

Table 1. Record
IdentifierMLC-T-ONC-004048
FieldOncology and biomedicine
SynonymsAdriamycin; doxorubicin hydrochloride
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004048",
  "term": "Hydroxydaunorubicin",
  "field": "Oncology and biomedicine",
  "definition": "A drug that comes from the bacterium Streptomyces peucetius and is used alone or with other drugs to treat many types of cancer, including leukemia, lymphoma, neuroblastoma, sarcoma, Wilms tumor, and certain cancers of the lung, breast, stomach, ovary, thyroid, and bladder. It is also being studied in the treatment of other types of cancer. Hydroxydaunorubicin damages the cell’s DNA and may kill cancer cells. It also blocks a certain enzyme needed for cell division and DNA repair. Hydroxydaunorubicin is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called Adriamycin and doxorubicin hydrochloride.",
  "synonyms": [
    "Adriamycin",
    "doxorubicin hydrochloride"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/hydroxydaunorubicin/"
}

Record 8,808 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.